CA Patent

CA2909370A1 — Sustained-release formulations of colchicine and methods of using same

Assigned to Murray and Poole Enterprises Ltd · Expires 2014-10-23 · 12y expired

What this patent protects

Pharmaceutical compositions of colchicine for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate- release component, the compositions of which can be selectively adjusted, respectively, to release the act…

USPTO Abstract

Pharmaceutical compositions of colchicine for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate- release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined or desired release profile. Method of treating or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA2909370A1
Jurisdiction
CA
Classification
—
Expires
2014-10-23
Drug substance claim
No
Drug product claim
No
Assignee
Murray and Poole Enterprises Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.